All News

Will a vegetarian diet and exercise actually help RA disease activity?

Save

d David Liew, FRACP

Nov 25, 2022

The exact role of diet, physical activity, and stress management in the management of RA has long been debated. While reasonable evidence has supported the importance of physical activity in patients with RA, its capacity to reduce disease activity via conventional measures such as DAS28 was less well delineated.

Read Article

Practical Guidance for the Clinical Rheumatologist in Unplanned Pregnancies

Save

d Catherine Sims, MD

Nov 25, 2022

Discussions regarding family planning, contraception, and pregnancy should be approached at each clinic visit to ensure providers understand patients’ personal goals. These conversations have the potential to decrease the risk of unplanned pregnancies. However, rheumatologists may need to manage unplanned pregnancies and the impacts of accidental teratogenic exposure.

Read Article

Tight control of proteinuria in newly diagnosed lupus nephritis

Save

d Md Yuzaiful Md Yusof, MRCP(UK), PhD

Nov 25, 2022

Since reduced proteinuria at one year is the best predictor of improved long-term renal outcomes in lupus nephritis, is there rationale to set a tighter treatment target?

Read Article

TNFi cycling in axSpA: Results from CorEVITAS Registy study Dr. Rachel Tate ( @uptotate) reviews abstract #1499 presented at #ACR22. https://t.co/rvzB2RHkAD https://t.co/m3uiXAvZmZ

Links:

https://bit.ly/3gDvNIu

Dr. John Cush RheumNow ( View Tweet)

Nov 25, 2022

JAKi Regulatory Decisions - FDA, EMA, Canada New download available! https://t.co/92qbWQbMm3 https://t.co/lEjyjwxYMo

Links:

https://bit.ly/3EYkHqT

Dr. John Cush RheumNow ( View Tweet)

Nov 25, 2022

New Treatments for SLE? Dr. Petri discusses abstract 1117 presented at #ACR22. Efficacy & Safety of Deucravacitinib, an Oral, Selective, Allosteric TYK2 Inhibitor, in Patients w/Active SLE: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study https://t.co/nKOserLdbb https://t.co/xhVsxT8BZW

Links:

https://bit.ly/3F359C0

Dr. John Cush RheumNow ( View Tweet)

Nov 25, 2022

RA Topic Panel RheumNow recaps the best & most interesting data presented at #ACR22 in RA. Panelists: Drs.Conway, Najm, Liew, Pope, Segan Follow: @RichardPAConway @AurelieRheumo @drdavidliew @Janetbirdope @JulianSegan https://t.co/GMqRmF2yXA https://t.co/WmYRTp49Rv

Links:

https://bit.ly/3OyoBde

Dr. John Cush RheumNow ( View Tweet)

Nov 25, 2022

Proposed Cancer Screening for Inflammatory Myositis Patients 11/12's plenary session features a novel proposal on how and which patients with Idiopathic Inflammatory Myopathy (IIM) should be screened for cancer. https://t.co/JlGGZ6UnOc https://t.co/86OnuLINPy

Links:

https://bit.ly/3gAhLHv

Dr. John Cush RheumNow ( View Tweet)

Nov 25, 2022

RheumNow Rheumatology Roundup Dr. Jack Cush and Dr. Arthur Kavanaugh discuss, dissect and deliberate the sessions and data presented at the #ACR22 meeting in Philadelphia. https://t.co/ppe5I5upvj https://t.co/su4SOS7MAg

Links:

https://bit.ly/3EXexY0

Dr. John Cush RheumNow ( View Tweet)

Nov 23, 2022

Monday #ACR22 Daily Recap https://t.co/QZTag5Hyol https://t.co/rgpxI9AOHP

Links:

https://bit.ly/3OtRpnd

Dr. John Cush RheumNow ( View Tweet)

Nov 23, 2022

FDA is investigating risk of severe hypocalcemia in dialysis patients taking Prolia (denosumab). After an interim safety data review reports of hypocalcemia w/ advanced CKD. Monitor Ca, use Ca & vit D supplements. Await further FDA information https://t.co/QMOtYs0eBY https://t.co/wzhIg53kCs

Links:

https://bit.ly/3tWmxSO

Dr. John Cush RheumNow ( View Tweet)

Nov 23, 2022

COVID Highlights Dr. Leonard Calabrese and Dr. Cassandra Calabrese share highlights on COVID data being presented at #ACR22 https://t.co/DEUykGt8pT https://t.co/sz8GRRGrPH

Links:

https://bit.ly/3GFTUAH

Dr. John Cush RheumNow ( View Tweet)

Nov 23, 2022

Do oral JAKs in atopic dermatitis cause VTE? Meta-analysis (15 RCTs, 466 993 pts) does NOT show increased risk of VTE associated with AD & JAK inhibitors (HR 0.95) w/ low VTE incidence (0.05%) w/ JAKi and (0.03%) placebo. https://t.co/mO2DHzjVJw https://t.co/aaC82UStob

Links:

https://bit.ly/3tSzjBR

Dr. John Cush RheumNow ( View Tweet)

Nov 23, 2022

Photovoice: A New Visual Research Method in Lupus Dr. Bella Mehta ( @bella_mehta) talks with Dr. Candace Feldman about Abstract 1099: Empowering Patients with Lupus Through Their Photographs at #ACR22. https://t.co/tPizbi16Om https://t.co/lYUXaGEerA

Links:

https://bit.ly/3Xrbles

Dr. John Cush RheumNow ( View Tweet)

Nov 23, 2022

Is toci an option in refractory PMR? #ACR22 📍double-blind RCT 💪101 pts w/GC-resistant PMR (mod. dz on pred. < 10 mg) 💉toci 8 mg/kg q4w + pred taper vs. placebo + pred taper over 24w 🌟49% in toci group stopped pred at week 24 vs. 20% in placebo 🌟AE similar b/t groups

Catherine Sims, MD DrCassySims ( View Tweet)

Nov 23, 2022

Just accepted in Arthritis & Rheumatology: Incidence, Prevalence, and Mortality of Lupus Nephritis: A Population-Based Study Over Four Decades—The Lupus Midwest Network (LUMEN) https://t.co/StigaFb3YZ

Links:

https://onlinelibrary.wiley.com/doi/abs/10.1002/art.42375?campaign=wolaccepteda…

ACR_Journals ACR_Journals ( View Tweet)

Nov 23, 2022

Impact of COVID 19 on Pregnancies in Women with RMD Dr. Cassy Sims ( @DrCassySims) discusses abstract 0950 at #ACR22. https://t.co/qbFRV5P3eP https://t.co/cmS4n15L5e

Links:

https://bit.ly/3TVoARG

Dr. John Cush RheumNow ( View Tweet)

Nov 23, 2022

What lifestyle factors affect TNF inhibitor efficacy in AxSpA? Dr Chao ( @doctorRBC) discusses Abstract 1510 at #ACR22 . Abstract 1510: Modifying Lifestyle Factors May Offer the Potential to Enhance the Outcome of TNF Inhibitors in AxSpA https://t.co/h8ZniRF5rO https://t.co/SZq5bvYPzt

Links:

https://bit.ly/3AEMERM

Dr. John Cush RheumNow ( View Tweet)

Nov 23, 2022

RA-ILD: an update Dr. Julian Segan ( @JulianSegan) discusses Abstract #1393 and Abstract #0245 presented at #ACR22. https://t.co/5Vk4NaWzqc https://t.co/doqhqeNgdX

Links:

https://bit.ly/3gq9qWZ

Dr. John Cush RheumNow ( View Tweet)

Nov 23, 2022

Are MDA criteria created equal in PsA? Dr. Rachel Tate ( @uptoTate ) reviews abstract #1496: Do Patients in MDA Report Low Disease Activity Regardless of Which of the MDA Criteria Are Met? Presented at #ACR22. https://t.co/H4wPHEV8D5 https://t.co/NqXYxXRNEX

Links:

https://bit.ly/3gs8mls

Dr. John Cush RheumNow ( View Tweet)

Nov 23, 2022

Topics

All News

Will a vegetarian diet and exercise actually help RA disease activity?

Save

Practical Guidance for the Clinical Rheumatologist in Unplanned Pregnancies

Save

Tight control of proteinuria in newly diagnosed lupus nephritis

Save

Do you get our email newsletter?

Will a vegetarian diet and exercise actually help RA disease activity? Save

Practical Guidance for the Clinical Rheumatologist in Unplanned Pregnancies Save

Tight control of proteinuria in newly diagnosed lupus nephritis Save

Will a vegetarian diet and exercise actually help RA disease activity?

Save

Practical Guidance for the Clinical Rheumatologist in Unplanned Pregnancies

Save

Tight control of proteinuria in newly diagnosed lupus nephritis

Save